Last C$0.24 CAD
Change Today +0.01 / 4.44%
Volume 74.6K
SVA On Other Exchanges
Symbol
Exchange
Berlin
Venture
OTC US
As of 3:59 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

sernova corp (SVA) Snapshot

Open
C$0.22
Previous Close
C$0.23
Day High
C$0.24
Day Low
C$0.21
52 Week High
04/21/14 - C$0.34
52 Week Low
07/16/13 - C$0.09
Market Cap
30.5M
Average Volume 10 Days
64.6K
EPS TTM
--
Shares Outstanding
129.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SERNOVA CORP (SVA)

Related News

No related news articles were found.

sernova corp (SVA) Related Businessweek News

No Related Businessweek News Found

sernova corp (SVA) Details

Sernova Corp., a clinical-stage health sciences company, focuses on the development and commercialization of medical technologies. The company’s proprietary platform technologies include Cell Pouch System, a scalable device providing a natural organ-like environment for therapeutic cells, such as insulin producing islets for diabetics; and Sertolin, a cell-based technology providing an immune-privileged environment for donor cells, reducing or eliminating the need for anti-rejection drugs. It also intends to commercialize the products for parkinson’s, spinal cord injury, and haemophilia diseases. The company is headquartered in London, Canada.

sernova corp (SVA) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: C$230.0K
Compensation as of Fiscal Year 2013.

sernova corp (SVA) Key Developments

Sernova Corp. Presents at BIO International Convention, Jun-23-2014

Sernova Corp. Presents at BIO International Convention, Jun-23-2014 . Venue: San Diego Convention Center, San Diego, California, United States.

Kevin M. Egan Joins Sernova Corp. as Chair of Business Advisory Board

Sernova Corp. announced that Mr. Kevin M. Egan, President, Borealis Biotechnology LLC, has joined Sernova as Chair of the Business Advisory Board. Mr. Egan brings over 25 years of experience in biopharma, and commercialization & partnering expertise to the company.

Sernova Announces Appointment of Nick Borrelly to Corporate Development Role

Sernova Corp. announce that Mr. Nick Borrelly is joining Sernova in a consultant corporate development role. Mr. Borrelly has over 25 years' experience in corporate/business development as well as marketing and sales in the pharmaceutical (Ciba-Geigy, Novartis and Sanofi-Aventis) and biopharma industries. As President of Camargue Consulting, he specializes in development, evaluation and in-licensing of technologies, initiation of strategic alliances with multi-national corporate partners, and leading sales and marketing teams for commercial stage products.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SVA:CN C$0.24 CAD +0.01

SVA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SVA.
View Industry Companies
 

Industry Analysis

SVA

Industry Average

Valuation SVA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 6.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SERNOVA CORP, please visit www.sernova.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.